In line with these data, our own data show that addition of TNFα enhanced CFU capacity upon first and serial plating in primary murine CML cells confirming that the cytokine preserves malignant stem cell quality. The gene discussed is TNF; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.